Dr Alison Birtle (Lancashire Teaching Hospitals, UK), Dr Ignacio Durán (Marques de Valdecilla University Hospital, Spain), Prof Evanguelos Xylinas (Bichat-Claude Bernard Hospital, France), Dr Giuseppe Simone (Regina Elena National Cancer Institute, Italy), and Dr Benjamin Pradere (La Croix Du Sud Hospital, France) discuss the latest updates in bladder cancer treatment for 2025.

The discussion highlights fresh trial data, evolving treatment strategies, and the importance of balancing medical outcomes with patients' quality of life.

Encouraging results are reported from trials such as CREST, ANZUP 1301, SunRISe-4, SunRISe-1 and NIAGARA.

The panel also review the FDA’s approval of TAR 200, explore advances in neoadjuvant approaches, and discuss the growing role of ctDNA analysis in guiding care.